Biocept Inc. (BIOC) move up 4.39% this morning: BIOC Price Rally Looks Real

Biocept Inc. (NASDAQ:BIOC) Relative Strength Index (RSI) is 63.89, with weekly volatility at 7.38% and ATR at 0.04. The BIOC stock’s 52-week price range has touched low of $0.21 and a $1.62 high. Intraday shares traded counted 21.27 million, which was -8.94% lower than its 30-day average trading volume of 19.52M. Its shares traded higher over the last trading session, gaining 4.39% on 05/21/20. The shares fell to a low of $0.403 before closing at $0.48. BIOC’s previous close was $0.46 while the outstanding shares total 29.22M. The firm has a beta of 0.60.

Investors have identified the Diagnostics & Research company Biocept Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $61.62 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Biocept Inc. (BIOC) Fundamentals that are to be considered.

When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For BIOC, the company has in raw cash 21.49 million on their books with 1.2 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 26260000 million total, with 6032000 million as their total liabilities.

BIOC were able to record -5.3 million as free cash flow during the third quarter of the year, this saw their quarterly net cash flow reduce by 12.19 million. In cash movements, the company had a total of -5.28 million as operating cash flow.

Potential earnings growth for Biocept Inc. (BIOC)

In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, Biocept Inc. recorded a total of 1.45 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 29.23% coming in sequential stages and their sales for the third quarter reducing by -23.29%.

What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 2.95 million trying to sell their products during the last quarter, with the result yielding a gross income of -1.5 million. This allows shareholders to hold on to 29.22M with the revenue now reading -0.11 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter.

Having a look at the company’s valuation, the company is expected to record -1.22 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on BIOC sounds very interesting.

Is the stock of BIOC attractive?

In the last 6 months, insiders have changed their ownership in shares of company stock by 0.03%.